| [1] |
Rowe WP, Huebner RL. Isolation of a cytopathic agent from human adenoids undergoing spontaneous degradation in tissue culture[J]. Soc Exp Bio Med, 1953, 84(3): 570-3. doi: 10.3181/00379727-84-20714
|
| [2] |
Arnold J, Jánoska M, Kajon AE, et al. Genomic characterization of human adenovirus 36, a putative obesity agent [J]. Virus Res, 2010, 149(2): 152-61. doi: 10.1016/j.virusres.2010.01.011
|
| [3] |
Shiko H, Aoki K. Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan[J]. J Clin Microbiol, 2009, 47(8): 2678-9. doi: 10.1128/JCM.r00313-09
|
| [4] |
Walsh MP, Seto J, Jones MS, et al. Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen [J]. J Clin Microbiol, 2010, 48(3): 991-3. doi: 10.1128/JCM.01694-09
|
| [5] |
Gao XQ, Jin Y, Xie ZP, et al. Study on the epidemiological of respiratory tract infections in children with adenovirus in Nanjing from 2010 to 2011 [J]. Chin J Virol, 2012, 5(12): 130-3.
|
| [6] |
Stercz B, Nagy K, Ongrádi J. Adenovirus infections in immunocompromised patients [J]. Orv Hetil, 2012, 153(48): 1896-904. doi: 10.1556/OH.2012.29496
|
| [7] |
Carstens EB. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009)[J]. Arch Virol, 2010, 155(1): 133-46. doi: 10.1007/s00705-009-0547-x
|
| [8] |
Tabain I, Ljubin-Sternak S, Cepin-Bogović J, et al. Adenovirus respiratory infections in hospitalized children: clinical findings in relation to species and serotypes[J]. Pediatr Infect Dis J, 2012, 31 (7): 680-4. doi: 10.1097/INF.0b013e318256605e
|
| [9] |
Tebruegge M, Curtis N. Adenoviruses in the immunocompromised host [J]. Adv Exp Med Biol, 2010, 659: 153-74. doi: 10.1007/978-1-4419-0981-7
|
| [10] |
黄国虹, 许文波.腺病毒新型别的研究进展[J].病毒学报, 2013, 29 (3): 342-8. http://www.cnki.com.cn/Article/CJFDTOTAL-BDXB201303018.htm
|
| [11] |
Smith JG, Wiethoff CM, Stewart PL, et al. Adenovirus [J]. Curr Top Microbiol Immunol, 2010, 343: 195-224.
|
| [12] |
Thaci B, Ulasov IV, Wainwright DA, et al. The challenge for gene therapy: innate immune response to adenoviruses[J]. Oncotarget, 2011, 2(3): 113-21. doi: 10.18632/oncotarget
|
| [13] |
Adhikary AK, Banik U, Okabe N, et al. Molecular characterization of human adenovirus type 8 (HAdV-8), including a novel genome type detected in Japan [J]. Jpn J Infect Dis, 2011, 64(6): 493-8. https://www.researchgate.net/publication/51829643_Molecular_Characterization_of_Human_Adenovirus_Type_8_HAdV-8_including_a_Novel_Genome_Type_Detected_in_Japan
|
| [14] |
Selvaraju SB, Kovac M, Dickson LM, et al. Molecular epidemiology and clinical presentation of human adenovirus infections in Kansas City children[J]. J Clin Virol, 2011, 51(2): 126-31. doi: 10.1016/j.jcv.2011.02.014
|
| [15] |
Russell WC. Adenoviruses: update on structure and function[J]. J Gen Virol, 2009, 90(Pt 1): 1-20. https://www.ncbi.nlm.nih.gov/pubmed/19088268
|
| [16] |
Roelvink PW, Lizonova A, Lee JG, et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F [J]. J Virol, 1998, 72(10): 7909-15. http://jvi.asm.org/content/72/10/7909.short
|
| [17] |
Cupelli K, Müller S, Persson BD, et al. Structure of adenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B adenoviruses[J]. J Virol, 2010, 84(7): 3189-200. doi: 10.1128/JVI.01964-09
|
| [18] |
Li H, Rhee EG, Masek-Hammerman K, et al. Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys [J]. J Virol, 2012, 86(19): 10862-5. doi: 10.1128/JVI.00928-12
|
| [19] |
Liszewski MK, Fang CJ, Atkinson JP. Inhibiting complement activation on cells at the step of C3 cleavage [J]. Vaccine, 2008, 26 (Suppl 8): I22-7. http://www.docin.com/p-1405110098.html
|
| [20] |
Persson BD, Schmitz NB, Santiago C, et al. Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens [J]. PLoS Pathog, 2010, 6 (9): e1001122. doi: 10.1371/journal.ppat.1001122
|
| [21] |
Nilsson EC, Storm RJ, Bauer J, et al. The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis[J]. Nat Med, 2011, 17(1): 105-9. doi: 10.1038/nm.2267
|
| [22] |
Nemerow GR, Pache L, Reddy V, et al. Insights into adenovirus host cell interactions fromstructural studies [J]. Virology, 2009, 384 (2): 380-8. doi: 10.1016/j.virol.2008.10.016
|
| [23] |
Darr S, Madisch I, Hofmayer S, et al. Phylogeny and primary structure analysis of fiber shafts of all human adenovirus types for rational design of adenoviral gene-therapy vectors[J]. J Gen Virol, 2009, 90(Pt 12): 2849-54. https://www.researchgate.net/publication/26719136_Phylogeny_and_Primary_Structure_Analysis_of_Fiber_Shafts_of_All_Human_Adenovirus_Types_for_Rational_Design_of_Adenoviral_Gene_Therapy_Vectors
|
| [24] |
Wang H, Li ZY, Liu Y, et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14[J]. Nat Med, 2011, 17(1): 96-104. doi: 10.1038/nm.2270
|
| [25] |
Lenman A, Müller S, Nygren MI, et al. Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells [J]. J Virol, 2011, 85(24): 13420-31. doi: 10.1128/JVI.06088-11
|
| [26] |
Waddington SN, Mcvey JH, Bhella D, et al. Adenovirus serotype 5 hexon mediates liver gene transfer [J]. Cell, 2008, 132(3): 397-409. doi: 10.1016/j.cell.2008.01.016
|
| [27] |
Short JJ, Vasu C, Holterman MJ, et al. Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors [J]. Virus Res, 2006, 122(1/2): 144-53. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_JJ028507995
|
| [28] |
Zhu J, Huang X, Yang Y. A critical role for type Ⅰ IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo [J]. Mol Ther, 2008, 16(7): 1300-7. doi: 10.1038/mt.2008.88
|
| [29] |
Muruve DA, Pétrilli V, Zaiss AK, et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response [J]. Nature, 2008, 452(7183): 103-7. doi: 10.1038/nature06664
|
| [30] |
Tian J, Xu Z, Smith JS, et al. Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo[J]. J Virol, 2009, 83(11): 5648-58. doi: 10.1128/JVI.00082-09
|
| [31] |
Zaiss AK, Vilaysane A, Cotter MJ, et al. Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response [J]. J Immunol, 2009, 182(11): 7058-68. doi: 10.4049/jimmunol.0804269
|
| [32] |
Junt T, Moseman EA, Iannacone M, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells [J]. Nature, 2007, 450(7166): 110-4. doi: 10.1038/nature06287
|
| [33] |
Onion D, Crompton LJ, Milligan DW, et al. The CD4 + T-cell response to adenovirus is focused against conserved residues within the hexon protein [J]. J Gen Virol, 2007, 88(Pt 9): 2417-25. http://d.scholar.cnki.net/detail/SJPD2059_U/SJPD12102203509895
|
| [34] |
Tang J, Olive M, Pulmanausahakul R, et al. Human CD8 + cytotoxic T cell responses to adenovirus capsid proteins[J]. Virology, 2006, 350(2): 312-22. doi: 10.1016/j.virol.2006.01.024
|
| [35] |
Matthes-Martin S, Boztug H, Lion T. Diagnosis and treatment of adenovirus infection in immunocompromised patients[J]. Expert Rev Anti Infect Ther, 2013, 11(10): 1017-28. doi: 10.1586/14787210.2013.836964
|
| [36] |
Kessler T, Hamprecht K, Feuchtinger T, et al. Dendritic cells are susceptible to infection with wild-type adenovirus, inducing a differentiation arrest in precursor cells and inducing a strong T-cell stimulation [J]. J Gen Virol, 2010, 91(Pt 5): 1150-4. https://www.researchgate.net/publication/40767695_Dendritic_cells_are_susceptible_to_infection_with_wild-type_adenovirus_inducing_a_differentiation_arrest_in_precursor_cells_and_inducing_a_strong_T-cell_stimulation
|
| [37] |
Ullman AJ, Hearing P. Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein [J]. J Virol, 2008, 82(15): 7325-35. doi: 10.1128/JVI.00723-08
|
| [38] |
Yee Mary Miu Waye. Chor wing sing.anti-viral drugs for human adenovirus [J]. pharmaceuticals, 2010, 3: 3343-54. doi: 10.3390/ph3103343
|
| [39] |
Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir[J]. Biol Blood Marrow Transplant, 2007, 13(1): 74-81. doi: 10.1016/j.bbmt.2006.08.040
|
| [40] |
商蕾, 曲章义, 魏凤香, 等.中药及其活性成分抗腺病毒研究进展[J].中草药, 2012, 43(10): 2071-6. http://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201210045.htm
|
点击查看大图
下载:
